Author: Wilson E.C.F.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.20, Iss.13, 2002-01, pp. : 879-889
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL advantage with sildenafil for erectile dysfunction
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 347, 2002-01 ,pp. :
By Angelis Konstantinopoulos Konstantinos Giannitsas Anastasios Athanasopoulos Dionisios Spathas Petros Perimenis
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. :
A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction
By Vitezic D.
Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. :
Sildenafil: A Review of its Use in Erectile Dysfunction
Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. :